Overview

The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets

Status:
COMPLETED

Trial end date:
2017-11-23

Target enrollment:

Participant gender:

Summary

A phase 1, single-center, double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and tolerability, pharmacokinetics, and preliminary efficacy of multiple administrations of TNP-2092 Capsules in combination with Rabeprazole Sodium Enteric-coated Tablets in asymptomatic healthy subjects with Helicobacter pylori infection

Phase:

PHASE1

Details

Lead Sponsor:

TenNor Therapeutics Inc.

Treatments:

TNP-2092